https://www.vpulsehk.com/endocrinology-1/nilemdo 2026-04-13 https://www.vpulsehk.com/endocrinology-1/an-update-on-the-role-of-sglt-2-inhibitor-in-the-kdigo-guideline-on-the-management-of-ckd 2026-04-13 https://www.vpulsehk.com/endocrinology-1/optimising-protein-intake-in-patients-with-chronic-kidney-disease 2026-04-13 https://www.vpulsehk.com/endocrinology-1/1-year-follow-up-on-the-transplantation-of-chemically-induced-pluripotent-stem-cell-derived-islets-in-a-type-1-diabetes-patient 2026-04-13 https://www.vpulsehk.com/endocrinology-1/a-daily-dark-chocolate-keeps-diabetes-away 2026-04-13 https://www.vpulsehk.com/endocrinology-1/transforming-diabetes-outcomes-the-clinical-power-of-insulin-glargine-u300 2026-04-13 https://www.vpulsehk.com/endocrinology-1/dapagliflozin-the-multifaceted-sglt2i-backed-by-cvd-real-nordic-results 2026-04-13 https://www.vpulsehk.com/endocrinology-1/ryzodeg%C2%AE 2026-04-13 https://www.vpulsehk.com/endocrinology-1/linagliptin-taisho%C2%AE 2026-04-13 https://www.vpulsehk.com/endocrinology-1/breaking-the-pathologic-combo-of-cvd-and-t2dm-%E2%80%93-now-and-then 2026-04-13 https://www.vpulsehk.com/endocrinology-1/glucophage-xr%C2%AE 2026-04-13 https://www.vpulsehk.com/endocrinology-1/why-semaglutide-users-are-quitting-the-cost-of-weight-loss 2026-04-13